PuraPharm Corp. Ltd. (1498) Income Statement

0 Followers

PuraPharm Corp. Ltd. Income Statement

Last quarter (Q4 2025), PuraPharm Corp. Ltd.'s total revenue was HK$163.82M, a decrease of -22.65% from the same quarter last year. In Q4, PuraPharm Corp. Ltd.'s net income was HK$-13.42M. See PuraPharm Corp. Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Total Revenue	HK$ 336.11M	HK$ 382.09M	HK$ 406.86M	HK$ 448.07M	HK$ 659.59M
Gross Profit	HK$ 180.16M	HK$ 205.14M	HK$ 216.63M	HK$ 260.59M	HK$ 421.85M
Operating Expenses	HK$ 210.14M	HK$ 234.56M	HK$ 282.67M	HK$ 325.09M	HK$ 404.23M
Depreciation and Amortization	HK$ 22.45M	HK$ 35.59M	HK$ 48.59M	HK$ 48.66M	HK$ 50.14M
EBITDA	HK$ 6.23M	HK$ 17.35M	HK$ -26.31M	HK$ -46.34M	HK$ -40.03M
Operating Income	HK$ -29.98M	HK$ -29.41M	HK$ -51.58M	HK$ -64.50M	HK$ 17.62M
Other Income/Expenses	HK$ -4.42M	HK$ 271.00K	HK$ -50.73M	HK$ -54.68M	HK$ -134.81M
Pretax Income	HK$ -34.41M	HK$ -28.83M	HK$ -102.31M	HK$ -119.18M	HK$ -117.19M
Net Income	HK$ -35.22M	HK$ -35.44M	HK$ -106.08M	HK$ -120.21M	HK$ -121.88M
Per Share Metrics
Basic EPS	HK$ -0.08	HK$ -0.09	HK$ -0.27	HK$ -0.30	HK$ -0.31
Diluted EPS	HK$ -0.08	HK$ -0.09	HK$ -0.27	HK$ -0.30	HK$ -0.31
Weighted Average Shares Outstanding	418.78M	395.06M	395.05M	394.58M	393.73M
Weighted Average Shares Outstanding (Diluted)	418.77M	395.05M	395.05M	394.58M	393.73M

Currency in HKD

PuraPharm Corp. Ltd. (1498) Income Statement

PuraPharm Corp. Ltd. Income Statement

PuraPharm Corp. Ltd. Earnings and Revenue History